Ceribell, Inc. (CBLL) stock
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30132% above fair value
$26.35−1.45 (-5.22%)
Close on Nov 12, 2026Market cap $1.01BP/E –Yield –
Ceribell cash
Cash and short-term investments held at the end of each period.
Ceribell's cash was $129.30M at Jun 30, 2026. For fiscal 2025 it was $159.30M, down 18.1% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $159.30M | -18.1% |
| FY2024 | Dec 31, 2024 | $194.40M | +463.6% |
| FY2023 | Dec 31, 2023 | $34.50M | -49.4% |
| FY2022 | Dec 31, 2022 | $68.24M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $129.30M | -27.1% |
| Q1 FY2026 | Mar 31, 2026 | $141.20M | -22.7% |
| Q4 FY2025 | Dec 31, 2025 | $159.30M | -18.1% |
| Q3 FY2025 | Sep 30, 2025 | $168.50M | +1094.2% |
| Q2 FY2025 | Jun 30, 2025 | $177.40M | +628.3% |
| Q1 FY2025 | Mar 31, 2025 | $182.70M | +462.3% |
| Q4 FY2024 | Dec 31, 2024 | $194.40M | +463.6% |
| Q3 FY2024 | Sep 30, 2024 | $14.11M | -68.9% |
| Q2 FY2024 | Jun 30, 2024 | $24.36M | -64.3% |
| Q1 FY2024 | Mar 31, 2024 | $32.49M | – |
| Q4 FY2023 | Dec 31, 2023 | $34.50M | – |
| Q3 FY2023 | Sep 30, 2023 | $45.32M | – |
| Q4 FY2022 | Dec 31, 2022 | $68.24M | – |
See a number that looks wrong?